why choose us

First received: June 02, 2023

Clinical Trial: The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Esophageal Cancer

Study Type: INTERVENTIONAL


Official Title: A Prospective Phase II Study of Prophylactic TPO Combined with Bone Marrow-sparing Intensity-modulated Radiotherapy to Reduce Platelet Inhibition in Patients with Esophageal Cancer Undergoing Concurre

Brief Summary: The goal of this interventional study is to explore the protective effect of prophylactic TPO combined with bone marrow sparing (BMS)-IMRT in patients with esophageal cancer undergoing concurrent chemoradiotherapy.The main purpose is to reduce the incidence of all grades of thrombocytopenia from 35% to less than 10% by the intervention of study.Participants will initiate concurrent chemoradiotherapy within 2 weeks after enrollment,and they will receive subcutaneous injection of recombinant human thrombopoietin…

Read more